# Olympus Innovation Ventures

> Olympus Innovation Ventures is a VC fund backing Medical, Biopharma and Biotechnology. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 2
- Last investment: Oct 2024
- Lead investor: 0%
- Last updated: Aug 2026

Olympus Innovation Ventures is an investment firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 50% |
| Biopharma | 1 | 50% |
| Biotechnology | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Alimetry | Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function. | $18M | Series A | Oct 28, 2024 |  |
| Universal Diagnostics | Universal Diagnostics S.L. (UDX) is a Spanish in-vitro diagnostics company developing a platform of minimally-invasive, blood-based solutions for detecting cancer early when treatment options are more plentiful and survival rates are still high. UDX believes that the best way to fight against cancer is by detecting it early.The UDX diagnosticplatform is designed to detect various cancer types, e.g. colorectal, liver, pancreatic, lung, and gastric cancer via one simple blood test. The assays rely on a curated set of proprietary methylation marker panels; a simple blood sample collected as part of a routine check-up, can be processed at a reference laboratory or hospital using standard equipment and then uploaded to the UDX Cloud for final algorithmic analysis.UDX’s first marker panel is a colorectal cancer screening test. The test identifies individuals who need to be referred for colonoscopy. Colorectal cancer is the 3rd most frequent cancer and 2nd deadliest cancer worldwide. The challenge is that colorectal cancer is mostly detected in late stages, with significantly decreased survival rates (11% survival rate in stage IV vs. 85% survival rate in stage I).To develop the test and execute its R&D and operations, UDX partners with international research institutions, hospitals, universities, and biobanks around the globe. |  | Series B | Aug 19, 2024 |  |

2 of 2 investments shown.

## Co-investors
- [American Gastroenterological Association](https://shizune.co/investors/profile/american-gastroenterological-association) — VC Fund, 1 deal together
- [Global from Day One](https://shizune.co/investors/profile/global-from-day-one-gd1) — VC Fund, 1 deal together
- [Hostplus](https://shizune.co/investors/profile/hostplus) — VC Fund, 1 deal together
- [Icehouse Ventures](https://shizune.co/investors/profile/icehouse-ventures) — VC Fund, 1 deal together
- [IP Group](https://shizune.co/investors/profile/ip-group-plc) — VC Fund, 1 deal together
- [K1W1](https://shizune.co/investors/profile/k1w1) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [Icehouse Ventures](https://shizune.co/investors/profile/icehouse-ventures) — VC Fund
- [Enterprise Angels](https://shizune.co/investors/profile/enterprise-angels) — VC Fund
- [K1W1](https://shizune.co/investors/profile/k1w1) — VC Fund

## Featured in investor lists
- [Medical Investors in New Zealand](https://shizune.co/investors/medical-investors-new-zealand)
- [Biotech VC Funds in New Zealand](https://shizune.co/investors/biotech-vc-funds-new-zealand)
- [Medical Device Investors in New Zealand](https://shizune.co/investors/medical-device-investors-new-zealand)
- [Medical Device VC Funds in New Zealand](https://shizune.co/investors/medical-device-vc-funds-new-zealand)

## FAQ

### What does Olympus Innovation Ventures invest in?

Olympus Innovation Ventures invests primarily in Medical, Biopharma and Biotechnology startups, most often at Series B stage. Most of the 2 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Olympus Innovation Ventures last invest?

The most recent investment recorded for Olympus Innovation Ventures closed in Oct 2024. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co